CHG-2022-0119

Analytical Method Change for Atezolimumab-R. Specification Change for Atezolimumab-R — minor update. Impacts 8 markets and 4 variations.

Change Number
CHG-2022-0119
Type
Analytical Method Change
Product
Atezolimumab-R
Status
Failed
Owner
Sarah Chen
Initiated
2023-01-10
Description

Specification Change for Atezolimumab-R — minor update

Impacted Markets (8)
CA — CanadaGB — United KingdomKR — South KoreaZA — South AfricaPL — PolandSE — SwedenBE — BelgiumPT — Portugal
Impacted Modules
3.2.S3.2.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved